Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim D Janda

Showing results (261-270 of 342) with videos related to

Pageof 35
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 11, 2017
Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG)Daniel Globisch, Lisa M Eubanks, Ryan J Shirey, et al.
Molecular Pharmaceutics|December 5, 2006
A molecular link between the active component of marijuana and Alzheimer's disease pathologyLisa M Eubanks, Claude J Rogers, Albert E Beuscher, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2007
Phage escape libraries for checkmate analysisTobin J Dickerson, Kathleen M McKenzie, Amanda S Hoyt, et al.
Chemical Communications (Cambridge, England)|July 6, 2017
A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behaviorNIcholas T Jacob, Kensaku Anraku, Atsushi Kimishima, et al.
Oncotarget|October 20, 2014
In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potentialPhilipp Raffeiner, Ruth Röck, Andrea Schraffl, et al.
RSC Medicinal Chemistry|July 5, 2021
Irreversible inhibition of BoNT/A protease: proximity-driven reactivity contingent upon a bifunctional approachLewis D Turner, Alexander L Nielsen, Lucy Lin, et al.
Pharmacology, Biochemistry, and Behavior|November 23, 2007
MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonistHeather N Richardson, Yu Zhao, Eva M Fekete, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2013
Onchocerca volvulus-neurotransmitter tyramine is a biomarker for river blindnessDaniel Globisch, Amira Y Moreno, Mark S Hixon, et al.
Journal of Neuroscience Research|September 8, 2021
Isoxazole-9 reduces enhanced fear responses and retrieval in ethanol-dependent male ratsMiranda C Staples, Melissa A Herman, Jonathan W Lockner, et al.
Biochemistry|July 19, 2006
Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediateZhuji Fu, Sheng Chen, Michael R Baldwin, et al.
Pageof 35

Showing results (261-270 of 342) with videos related to

Sort By:
Pageof 35
Bioorganic & Medicinal Chemistry Letters|June 11, 2017
Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG)Daniel Globisch, Lisa M Eubanks, Ryan J Shirey, et al.
Molecular Pharmaceutics|December 5, 2006
A molecular link between the active component of marijuana and Alzheimer's disease pathologyLisa M Eubanks, Claude J Rogers, Albert E Beuscher, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2007
Phage escape libraries for checkmate analysisTobin J Dickerson, Kathleen M McKenzie, Amanda S Hoyt, et al.
Chemical Communications (Cambridge, England)|July 6, 2017
A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behaviorNIcholas T Jacob, Kensaku Anraku, Atsushi Kimishima, et al.
Oncotarget|October 20, 2014
In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potentialPhilipp Raffeiner, Ruth Röck, Andrea Schraffl, et al.
RSC Medicinal Chemistry|July 5, 2021
Irreversible inhibition of BoNT/A protease: proximity-driven reactivity contingent upon a bifunctional approachLewis D Turner, Alexander L Nielsen, Lucy Lin, et al.
Pharmacology, Biochemistry, and Behavior|November 23, 2007
MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonistHeather N Richardson, Yu Zhao, Eva M Fekete, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2013
Onchocerca volvulus-neurotransmitter tyramine is a biomarker for river blindnessDaniel Globisch, Amira Y Moreno, Mark S Hixon, et al.
Journal of Neuroscience Research|September 8, 2021
Isoxazole-9 reduces enhanced fear responses and retrieval in ethanol-dependent male ratsMiranda C Staples, Melissa A Herman, Jonathan W Lockner, et al.
Biochemistry|July 19, 2006
Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediateZhuji Fu, Sheng Chen, Michael R Baldwin, et al.
Pageof 35